Octane OC

The Octane Impact Fund is more than a source of support—it’s a catalyst for progress and innovation in Orange County. As we approach Giving Tuesday, we’re inviting you to be part of a movement that fuels the next generation of growth, high-paying jobs, and leadership in our community. Supporting the Octane Impact Fund means investing in the legacy we leave behind. Learn how your contribution can help us build a brighter future for Orange County. Together, we’re making a lasting impact that will benefit our community for generations to follow. Donate today to be part of this transformative journey: https://lnkd.in/giKvF2jS #ImpactFund #EmpowerInnovation #FuelSuccess #OCInnovation #OrangeCountyLegacy

Kickstart 2025 with bold ideas and transformative leadership! 💡 Join us this week on January 15th for the Women Leaders of Octane virtual meeting, featuring Dr. Sophia Ononye, PhD MPH MBA, a powerhouse in scientific storytelling, sharing how to turn complex ideas into innovation-driving narratives. Don’t miss this chance to amplify your voice and make an impact Register now: https://lnkd.in/gF3bzAc5 #WLO2025

Our Aesthetics Tech Forum was an incredible showcase of innovation and insights in the aesthetics industry! From cutting-edge devices to transformative discussions on AI, private equity, and market resilience, the event truly highlighted the future of aesthetic technology. Huge thanks to everyone who made it such a success! #ATF2025 #AestheticsInnovation

Wrapping up #ATF2025 with the panel discussion on Laser & Energy-Based Devices, moderated by Amber Edwards, CEO of Sinclair, explored the latest advancements shaping the aesthetics industry. Leaders from across the field provided valuable insights into innovation, technology trends, and patient care. Rob Catlin, CEO of miraDry, Inc., emphasized the need to distinguish true innovation from mere “new” products, highlighting the importance of refining procedures and utilizing AI and machine learning to improve protocols and outcomes. Irina Erenburg, PhD, CEO of AVAVA, INC., spoke about the complexities of the energy-based device space, advocating for biologically driven solutions that address gaps in technology. Her team’s eight years of development in focal point technology underscores the dedication required for meaningful progress. Pasha Sateri, Global Vice President, Strategic Marketing and Global Services at Solta Medical, highlighted the importance of effectively communicating new technologies’ benefits to consumers, ensuring safety and value are front and center. Dr. Jessica Wu, Cosmetic Dermatologist and CEO & Founder of Residen, shared patient insights, noting that effectiveness and comfort take priority over cost. She also emphasized how AI can make treatments safer, more predictable, and consistent, while integrating lifestyle modifications to support skin health. This discussion showcased how laser and energy-based devices are advancing through data-driven solutions, precision energy delivery, and holistic approaches to aesthetics. As demand grows for preventative care and treatments catering to all skin tones, the future of aesthetics lies in the seamless integration of innovation, wellness, and patient-centered care.

Wayne Liu, Chief Growth Officer and President of the Americas at Perfect Corp., unveiled three groundbreaking AI-driven innovations transforming skincare and aesthetics during our session "Perfecting Aesthetics: AI-Driven Innovations in Skin and Surgical Simulation": Skin Care Pro: HD AI Skin Analysis identifies five wrinkle types and reconstructs facial structures from just three photos, providing unmatched precision. AI Aesthetic Simulator: Simulates post-surgical outcomes with 27 customizable options, empowering practitioners and clients to make informed adjustments before procedures. Skincare GPT: Offers rapid, AI-driven skin consultations in five seconds, addressing everyday skincare concerns while bridging to deeper consultations when needed. Perfect Corp. is leading the way in using AI to enhance personalization, precision, and confidence in aesthetics, empowering both practitioners and patients alike

The science of beauty is evolving, and we’re on the cusp of something extraordinary. During a captivating session, Steven Dayan, MD, FACS (Impressions Chicago) explored the profound connection between beauty, the human experience, and groundbreaking research on oxytocin. Known as the "love hormone," oxytocin has remarkable effects on the skin, improving tissue healing, reducing skin aging, and enhancing confidence, self-esteem, and pro-social interactions. Its unique positive feedback loop allows the skin to stimulate oxytocin release in the brain, creating a powerful connection between emotional well-being and physical health. Dr. Dayan highlighted nature’s influence on these processes, from the sun’s mood-elevating effects to jasmine’s ability to increase oxytocin levels by stimulating Piezo1 receptors. These insights have paved the way for a new category of innovation in skincare: MoodCeutricals, which harness oxytocin’s potential to improve both skin quality and emotional well-being. In a recent study, this approach demonstrated statistically significant improvements in 7 out of 8 categories, and the upcoming XOMD product, set to launch on 1/23/25, is poised to redefine the industry. Beyond the science, Dr. Dayan emphasized the irreplaceable human ability to feel and connect—qualities that artificial intelligence can never replicate. Sentient skin differentiates us from robots, producing stress hormones, feel-good peptides, and oxytocin, reminding us of the profound ways we communicate and act on a subconscious level. As we embrace this new era of beauty and wellness, it’s clear that beauty is not just seen—it’s felt.

Private equity is playing an increasingly significant role in the aesthetics space, and navigating its complexities is crucial for the future of patient care and practice success. During this insightful panel, moderated by Ari J. Markenson, J.D., M.P.H., (Venable LLP), key industry leaders shared their expertise: David Barr (Empower Aesthetics) emphasized the importance of cultural alignment and preserving brand identity to maintain patient loyalty and drive better outcomes. Steven Dayan, MD, FACS (Impressions Chicago) highlighted the nuanced nature of PE partnerships, including both the opportunities and challenges they present for practices. G. Benjamin Hernandez (Skytale Group) stressed the critical need for due diligence, understanding deal structures, and choosing the right PE partners to ensure long-term success. Jason Bloom, MD, FACS (Bloom Facial Plastic Surgery ) shared valuable insights on maintaining autonomy and prioritizing patient experience, even as the industry evolves. The discussion reinforced a powerful message: successful partnerships in aesthetics require alignment, transparency, and a commitment to preserving the unique value of each practice. As our industry continues to grow, we remain focused on supporting initiatives that prioritize both patient care and practice integrity.

The future of medical aesthetics is transforming as we head toward 2030. During our panel, moderated by Dr. Steve Yoelin, industry leaders shared insights on emerging treatments and their impact on patient care and business growth: Jeff Bedard (Crown Laboratories, Inc.): Highlighted advancements in natural rejuvenation and leveraging skin bacteria for healthier outcomes. Lana Kerr (Lumisque Skincare/ CO2LIFT Carboxytherapy Gel): Discussed the regenerative benefits of CO₂ Lift and the importance of wellness education. James Hartman (Ourself): Reflected on the shift to natural-looking trends and innovation in skincare delivery. Drew Taylor, PhD (Acorn Biolabs): Predicted aesthetics leading the way in personalized and regenerative medicine. Rui Avelar, MD (Evolus): Shared impressive safety data on Juveau and strategies to engage younger demographics. With innovations redefining rejuvenation, the next decade promises a more personalized, natural, and patient-centered approach to aesthetics.

We’re wrapping up Day 1 of #ATF2025 with our 2nd group of Presenting Companies featured presentations from some of the most innovative companies driving the future of aesthetics: Innopath Therapeutics - Creating the New Standard of Care for Non-Melanoma Skin Cancer ArtifeX AI - AI-powered robotic platform to automate injectables and laser treatments. Ponce AI - Educate patients and sell more treatments with Al Facial Analysis NovoThelium - Modernizing nipple reconstruction. Each company presented innovative solutions designed to propel the aesthetics industry forward, bringing fresh perspectives and transformative technologies to the forefront. A heartfelt thank you to our emcee, Bill Walker, Founder & CEO of Aesthetic Brokers, for leading this impactful session. We also deeply appreciate our esteemed panel of judges for their invaluable expertise and insightful feedback: Gregory Buford, MD, FACS, PCEO, BEAUTY BY BUFORD Fauad Hasan, Co-Founder & Chair of the Board, Appiell.ai Adam Finegan, Director, Search & Evaluation, Allergan Aesthetics, an AbbVie Company

The panel on the Growth of Hair, moderated by Ken Washenik, MD, PhD, Chief Medical Officer at Bosley Medical Group, brought together industry experts Wajdie Ahmad (Amplifica Holdings Group), Andrea Daniels (Strive Compounding Pharmacy), Daniel Gil, PhD (Pelage Pharmaceuticals), Danielle Leavitt (Xtressé), and Dr. Tess Mauricio, M.D., FAAD (M Beauty Clinic) to discuss the latest innovations in treating hair loss. Non-surgical treatments took center stage, with Tess Mauricio highlighting hair restoration as one of 2025's biggest trends and emphasizing the importance of education and comprehensive care for effective results. Andrea Daniels noted success with topical peptides for post-COVID hair loss patients, while panelists discussed the practicality and tolerability of low-level laser therapies, including laser-based helmets, as at-home treatment options. Wajdie Ahmad pointed to the need for better standards of care, focusing on therapies that activate the hair cycle and address underlying causes of hair thinning. By addressing the underlying causes of hair loss through advanced therapies like topical peptides and low-level laser treatments, while setting higher standards for care, the industry is poised to deliver transformative results. With patient awareness growing and trends pointing toward comprehensive, non-surgical solutions, hair restoration is not just evolving—it’s becoming a cornerstone of aesthetics.